AXGN
$21.61
Axogen
($.89)
(3.96%)
AXGN
Earnings Whisper ®
N/A
1st Quarter March 2021
Consensus:  ($0.20)
Revenue:  $27.91 Mil
Monday
May 24
4:00 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when AXGN reports earnings?
Beat
Meet
Miss

Where is AXGN's stock price going from here?
Up
Flat
Down
Stock chart of AXGN
Analysts
Summary of analysts' recommendations for AXGN
Score
Grade
Pivots
Resistance
$23.63
$23.17
$22.39

$21.93

Support
$21.15
$20.69
$19.91
Tweet
Growth
Description
AxoGen, Inc. engages in developing and marketing surgical solutions for peripheral nerves. The company's portfolio of products includes Avance Nerve Graft(R), AxoGuard Nerve Connector(R), AxoGuard Nerve Protector(R), Avive Soft Tissue Membrane(R), AcroVal Neurosensory & Motor Testing System(R) and AxoTouch Two-Point Discriminator(R). It operates primarily in the United States, Canada, the United Kingdom, and other European and international countries. AxoGen Inc., formerly known as AxoGen Corp., is based in FL, United States.
Peers
MedtronicVarian Medical SystemsCONMED